Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Childhood Lymphoblastic Lymphoma"'
Publikováno v:
Pediatric hematology and oncology. 39(3)
Childhood lymphoblastic lymphoma (LL) is a highly aggressive neoplasm which has achieved favorable survival outcomes in many developed countries. However, few studies have reported treatment outcomes of childhood LL in resource-limited counties, nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a5fb34c8e26921f408e1fcaf952775a8
https://pubmed.ncbi.nlm.nih.gov/34378480
https://pubmed.ncbi.nlm.nih.gov/34378480
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Emanuele S.G. d'Amore, A Lombardi, Alessandra Sala, Nicola Santoro, Maria Luisa Moleti, Alberto Garaventa, Elisa Carraro, Marta Pillon, Valentino Conter, Luca Lo Nigro, Paolo D'Angelo, R. Mura, Fulvio Porta, Maurizio Aricò, Angelo Rosolen, Fiorina Casale, M. Piglione, Salvatore Buffardi, Simone Cesaro, Giuseppe Basso, Lara Mussolin
Publikováno v:
Pediatric Blood & Cancer. 62:1388-1394
Background Treatment intensification was considered a suitable strategy to increase the cure rate of lymphoblastic lymphoma (LBL) in children. Procedure The AIEOP LNH-97 trial was run between 1997 and 2007 for newly diagnosed LBL in patients aged les
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ebcf321217c3bad1753b828a3cf09f9
https://doi.org/10.1002/pbc.25469
https://doi.org/10.1002/pbc.25469
Autor:
Amir Fadhil Al-Darraji, Salma Abbas Al-Hadad, Raghad Majid Al-Saeed, Samaher Abdulrazzaq Fadhil
Publikováno v:
مجلة كلية الطب, Vol 56, Iss 4 (2015)
Background: Lymphoblastic lymphomas (LBL) are neoplasms of precursor T cells and B cells, or lymphoblasts. The term lymphoblastic lymphoma has been used to describe predominantly lymph node– based disease; however, clinical distinction between LBL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fad92d5fcd55c5fec24cb1d1ddbb0799
https://doi.org/10.32007/jfacmedbagdad.564541
https://doi.org/10.32007/jfacmedbagdad.564541
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Y J Gao, Ci Pan, Huiliang Xue, Zhou Xu, Jing Chen, Hui Miao, Qi-Dong Ye, Hongsheng Wang, Xiaowen Qian, Jingyan Tang, Fengjuan Lu, Xiaowen Zhai, Min Zhou, Jun Li, Jian-Hua Meng
Publikováno v:
Pediatric Blood & Cancer. 61:659-663
Background This retrospective cohort study analysed the clinical characteristics and outcomes of patients with childhood lymphoblastic lymphoma (LBL) treated in Shanghai, China. Procedure From 2001 to 2010, 108 evaluable patients ≤16 years of age w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1ee8a75197946af2828d1e34e47a490
https://doi.org/10.1002/pbc.24848
https://doi.org/10.1002/pbc.24848
Autor:
Frédéric Millot, Francoise Mechinaud, Alice Ferster, Anne Uyttebroeck, Emannuel Plouvier, Patrick Boutard, Pierre Philippet, Marleen Renard, Jutte van der Werff ten Bosch, Yves Bertrand, Alain Robert, Els Vandecruys, Brigitte Lescoeur, Yves Benoit, Liliana Baila, Françoise Mazingue, Martine Munzer, Stefan Suciu
Publikováno v:
Pediatric Blood & Cancer. 57:119-125
Background Intensive chemotherapy has markedly improved the survival of children with acute lymphoblastic leukaemia (ALL) or lymphoblastic lymphoma (LL). Evaluation of late effects and analysis of factors contributing to their occurrence has become o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33610788c21c102bcade12fd3cb6c30f
https://doi.org/10.1002/pbc.23083
https://doi.org/10.1002/pbc.23083
Publikováno v:
Pediatric Blood & Cancer. 52:591-595
Background and Procedure To assess the clinical course with response to second-line treatment and to evaluate the role of hematopoietic stem cell transplantation (SCT) in children with relapsed or primary refractory lymphoblastic lymphoma (LBL), we a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3854b654e0655824e12042cebbb47c07
https://doi.org/10.1002/pbc.21941
https://doi.org/10.1002/pbc.21941
Autor:
Frederick G. Behm, Mlissa M. Hudson, Raul C. Ribeiro, Bassem I. Razzouk, Mihaela Onciu, Yinmei Zhou, John T. Sandlund, Ching-Hon Pui, Nobuko Hijiya, Dario Campana
There has been a steady improvement in cure rates for children with advanced-stage lymphoblastic non-Hodgkin's lymphoma. To further improve cure rates whereas minimizing long-term toxicity, we designed a protocol (NHL13) based on a regimen for childh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25f5957d38303fde5cf946aa70388fff
https://europepmc.org/articles/PMC2843413/
https://europepmc.org/articles/PMC2843413/
Publikováno v:
Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society. 8(5)
Cytogenetic analyses of lymphomas commonly reveal nonrandom chromosomal abnormalities, but there are relatively few reports in childhood lymphoblastic lymphoma (LL). We retrospectively reviewed G-banded karyotypic analyses performed at Arkansas Child
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b103fab8dba36d74bb3606ab65a8eb4e
https://pubmed.ncbi.nlm.nih.gov/16211447
https://pubmed.ncbi.nlm.nih.gov/16211447